NINobuyuki Ishibashi

Nobuyuki Ishibashi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nobuyuki Ishibashi has a total of 209 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Tetrahydrobiopterin restores oligodendrocyte maturation after hypoxic white matter injury by reprogramming translational output

    by Nemanja Sarić, Ingrid Antonios, Karl Heiser, Alissa Ballard, Kennedy Miller, Iman Mansoor, May T Rajtboriraks, Shreya Chandran, Evan Goldstein, Nobuyuki Ishibashi

    Background: Complex congenital heart defects (CHDs) are frequently associated with chronic cerebral hypoxemia, leading to impaired white matter maturation. One proposed mechanism involves hypoxia-induced disruption of the nitric oxide synthase cofactor tetrahydrobiopterin (BH4), resulting in oxidative stress and impaired oligodendrocyte (OL) development. While our previous studies found BH4 supplementation improves hypoxia-induced white matter dysmaturation, the molecular mechanisms remain incompletely understood. Because OL maturation requires coordinated translational control, we hypothesized that BH4 promotes white matter maturation by restoring translation programs disrupted by hypoxia. Methods: Translating Ribosome Affinity Purification sequencing (TRAP-seq) was performed on OL lineage cells isolated from transgenic ribosomal reporter mice exposed to chronic hypoxia (10.5% O₂, postnatal day 3–11) with or without daily BH4 treatment. Differential translation, weighted gene co-expression network analysis, pathway enrichment, RNAscope, and immunohistochemistry identified translational programs associated with hypoxia and BH4-mediated rescue. Results: Developmental hypoxia extensively altered the OL translatome, suppressing transcripts associated with OL maturation while enriching pathways related to translational regulation and cellular stress. Network analyses identified BH4-responsive gene modules enriched for OL maturation, protein metabolism, and translation-related processes. BH4 partially reversed hypoxia-induced translational changes, restored OL maturation gene expression, and normalized nuclear localization of the lineage regulator OLIG1, consistent with recovery of maturation-associated regulatory programs. Conclusions: Developmental hypoxia disrupts OL maturation through coordinated alterations in ribosome-associated gene expression and post-transcriptional regulatory pathways. BH4 promotes recovery of OL maturation programs, including restoration of translation-related networks and OLIG1 nuclear localization, providing mechanistic insight into BH4-supported white matter maturation under chronic hypoxic conditions. Research Perspective: What New Question Does This Study Raise?: Developmental hypoxemia in congenital heart disease remodels the oligodendrocyte translatome, raising the question of whether translational dysregulation represents a fundamental and therapeutically targetable mechanism underlying white matter dysmaturation in other forms of perinatal brain injury. What Question Should Be Addressed Next?: Future studies should determine how BH4 restores ribosome-associated translation of oligodendrocyte maturation programs, establish whether these molecular changes increase myelin protein synthesis and improve long-term neurodevelopmental outcomes, and define the cross-species efficacy for clinical translation. Clinical Research Implication: These findings provide a mechanistic rationale for evaluating BH4 as a neuroprotective adjunct therapy to preserve white matter development in fetuses and infants with congenital heart disease experiencing chronic cerebral hypoxemia.

  • Mesenchymal Stromal Cells Improve Postoperative Cardiac Dysmaturation in a Juvenile Porcine Model

    by Akihisa Furuta, Hironobu Nishiori, Artur Aharonyan, Anna Devoto, Esomchi Jachin Ejim, Ramini Paruchuri, Soichiro Henmi, Kei Kobayashi, Kumi Kobayashi, Stephen Lin, et al.

    Background: Mesenchymal stromal cells (MSCs) are known to protect tissues from inflammation and oxidative stress. This study aimed to evaluate the effects of cardiopulmonary bypass (CPB) and MSC treatment on cardiac maturation in a juvenile porcine model. Methods: Two‐week‐old Yorkshire pigs were randomly assigned to 3 groups: (1) control (n=10), (2) CPB (n=10), and (3) CPB + MSC (n=15). MSCs (1 × 10 7 cells/kg) were administered via CPB. Acute and long‐term responses were evaluated at 3 hours and 4 weeks post‐CPB. In addition to histological analysis, diffusion tensor imaging was used to assess cardiac microstructures. Results: Oxidative stress marker 8‐hydroxy‐2ʹ‐deoxyguanosine (8‐OHdG) and Iba1 + (ionized calcium‐binding adapter molecule 1) monocytes/macrophages increased at 3 hours post‐CPB compared with controls. The increases in cardiac 8‐OHdG and monocytes/macrophages were still observed at 4 weeks, indicating prolonged oxidative/inflammatory stresses resulting from CPB. MSC delivery normalized both acute and prolonged oxidative/inflammatory insults. At 4 weeks, CPB caused reduced connexin 43 expression and increased cross‐sectional area of cardiomyocytes. Consistent with cellular changes, alterations in fractional anisotropy and helix and propagation angles were identified using diffusion tensor imaging 4 weeks post‐CPB. Additionally, differential tractography revealed impairments in fiber organization, demonstrating deleterious impacts of CPB on cellular and microstructural maturations of the developing heart. MSC delivery not only mitigated CPB‐induced oxidative/inflammatory stresses but also improved cellular and structural impairments following pediatric cardiac surgery. Conclusions: CPB induces oxidative and inflammatory stresses, thereby causing cellular and structural changes in the developing heart. MSC treatment showed promise in improving CPB‐induced impairments of cardiac maturation in neonates and infants undergoing cardiac surgery.

  • Open Access

    Mesenchymal Stromal Cells Mitigate Prolonged Cardiopulmonary Bypass-Induced Neuroinflammation

    by Kei Kobayashi, Takuya Maeda, Nemanja Saric, Kamil Sarkislali, Akihisa Furuta, Chase D McCann, Patrick J Hanley, David Zurakowski, Nobuyuki Ishibashi

    Objectives: Bone marrow-derived mesenchymal stromal cell (BM-MSC) delivery through cardiopulmonary bypass (CPB) can modulate CPB-induced systemic inflammation and inhibit microglial activation. The present study assessed whether BM-MSC treatment remains effective for extensive inflammatory reactions. Methods: Two-week-old piglets were randomized into control, CPB with deep hypothermic circulatory arrest (DHCA), CPB with BM-MSCs, CPB with DHCA plus 180 min extended perfusion, and extended CPB with BM-MSCs. Human BM-MSCs (1 × 107 cells/kg) were delivered via the CPB circuit during rewarming. We measured 9 porcine plasma cytokines. Brains were harvested for microglial immunohistochemistry and premotor cortex RNA-sequencing. Results: A total of 20 piglets were included (n = 4 per group). An extended CPB period increased the number of white matter microglia and plasma interferon-g (IFN-g) and TNF-a levels compared to standard CPB (P < .05). Notably, BM-MSCs normalized the extensive microglia expansion resulting from prolonged CPB (P < .001). In addition to reduced IFN-g and increased IL-10, BM-MSCs increased IL-1b and IL-8 levels, suggesting possible immunosuppressive reactions observed under inflammatory microenvironment. Gene ontology analyses in the premotor cortex post-CPB found involvement of NF-kB signalling. While there was a positive correlation between IFN-g and microglia expansion/activation, IL-10 levels were inversely correlated with the number of microglia. Consistent with immunosuppressive roles in the inflammatory environment, we found inverse correlations between IL-1b and IL-8 levels and CPB-induced microglial activation (P < .01). Conclusions: BM-MSC administration via CPB shows promise for reducing extensive inflammatory stress. Further investigation using this model will elucidate CPB-induced unique pathological events in the developing brain and mechanisms underlying the therapeutic actions of BM-MSC.


  • Open Access

    Outer radial glia promotes white matter regeneration after neonatal brain injury

    by Hideo Jinnou, Lauren M. Rosko, Satoshi Yamashita, Soichiro Henmi, Jaya Prasad, Van K. Lam, Artur Agaronyan, Tsang-Wei Tu, Yuka Imamura, Kazuya Kuboyama, et al.


  • Open Access

    Significance of birth in the maintenance of quiescent neural stem cells

    by Koya Kawase, Yasuhisa Nakamura, Laura Wolbeck, Shoko Takemura, Kei Zaitsu, Takehiro Ando, Hideo Jinnou, Masato Sawada, Chikako Nakajima, Rasmus Rydbirk, et al.

    Birth is one of the most important life events for animals. However, its significance in the developmental process is not fully understood. Here, we found that birth-induced alteration of glutamine metabolism in radial glia (RG), the embryonic neural stem cells (NSCs), is required for the acquisition of quiescence and long-term maintenance of postnatal NSCs. Preterm birth impairs this cellular process, leading to transient hyperactivation of RG. Consequently, in the postnatal brain, the NSC pool is depleted and neurogenesis is decreased. We also found that the maintenance of quiescent RG after preterm birth improves postnatal neurogenesis. This study demonstrates the significance of birth in the maintenance of quiescent NSCs.


  • Open Access

    Ciliopathy interacts with neonatal anesthesia to cause non-apoptotic caspase-mediated motor deficits

    by Nemanja Sarić, Zeynep Atak, Courtni Foster Sade, Nikita Reddy, Gabrielle Bell, Christina Tolete, May T. Rajtboriraks, Kazue Hashimoto-Torii, Vesna Jevtović-Todorović, Tarik F. Haydar, et al.

    Increasing evidence suggests that anesthesia may induce developmental neurotoxicity, yet the influence of genetic predispositions associated with congenital anomalies on this toxicity remains largely unknown. Children with congenital heart disease often exhibit mutations in cilia-related genes and ciliary dysfunction, requiring sedation for their catheter or surgical interventions during the neonatal period. Here we demonstrate that briefly exposing ciliopathic neonatal mice to ketamine causes motor skill impairments, which are associated with a baseline deficit in neocortical layer V neuron apical spine density and their altered dynamics during motor learning.. These neuromorphological changes were linked to augmented non-apoptotic neuronal caspase activation. Neonatal caspase suppression rescued the spine density and motor deficits, confirming the requirement for sublethal caspase signaling in appropriate spine formation and motor learning. Our findings suggest that ciliopathy interacts with ketamine to induce motor impairments, which is reversible through caspase inhibition. Furthermore, they underscore the potential for ketamine- induced sublethal caspase responses in shaping neurodevelopmental outcomes.

  • Open Access

    The role of primary cilia in congenital heart defect-associated neurological impairments

    by Nemanja Sarić, Nobuyuki Ishibashi

    Congenital heart disease (CHD) has, despite significant improvements in patient survival, increasingly become associated with neurological deficits during infancy that persist into adulthood. These impairments afflict a wide range of behavioral domains including executive function, motor learning and coordination, social interaction, and language acquisition, reflecting alterations in multiple brain areas. In the past few decades, it has become clear that CHD is highly genetically heterogeneous, with large chromosomal aneuploidies and copy number variants (CNVs) as well as single nucleotide polymorphisms (SNPs) being implicated in CHD pathogenesis. Intriguingly, many of the identified loss-of-function genetic variants occur in genes important for primary cilia integrity and function, hinting at a key role for primary cilia in CHD. Here we review the current evidence for CHD primary cilia associated genetic variants, their independent functions during cardiac and brain development and their influence on behavior. We also highlight the role of environmental exposures in CHD, including stressors such as surgical factors and anesthesia, and how they might interact with ciliary genetic predispositions to determine the final neurodevelopmental outcome. The multifactorial nature of CHD and neurological impairments linked with it will, on one hand, likely necessitate therapeutic targeting of molecular pathways and neurobehavioral deficits shared by disparate forms of CHD. On the other hand, strategies for better CHD patient stratification based on genomic data, gestational and surgical history, and CHD complexity would allow for more precise therapeutic targeting of comorbid neurological deficits.


  • Establishing Optimal Control Cohorts for Phase 1 Trials: Retrospective Analysis of Clinical and Biological Outcomes in Neonates and Infants Undergoing Two-Ventricle Repair

    by Kumi Kobayashi, Kei Kobayashi, Christopher Liu, Julia Ryan, David Zurakowski, Nobuyuki Ishibashi

    Phase 1 trials are primarily conducted to evaluate the safety and feasibility of new interventions, usually without recruiting control patients. This retrospective study aims to characterize clinical and biological outcomes in historical and contemporary cases of neonates and infants undergoing two-ventricle repair to facilitate future secondary endpoint analyses for such trials. This retrospective study included neonates/infants (ages ≤ 6 months) who underwent two-ventricle repair between 2015 and 2021 using the same criteria as our phase 1 trial (n = 199). Patients were allocated into the ventricular septal defect (n = 61), the Tetralogy of Fallot (TOF, n = 88), and the transposition of the great arteries (n = 50) groups with an additional comparison between two eras (2015–2019 vs. 2020–2021). Patient characteristics and most variables assessed were different between the three diagnostic groups indicating the importance of diagnostic matching for secondary analyses. Although the era did not alter cerebral/somatic oxygenation, ventricular function, neuroimaging findings, and complication rates, we observed improvement of inotropic and/or vasoactive-inotropic scores in all groups during the more recent era. In 2020–2021, the age and the body weight at the operation were higher, and hospital stay was shorter in the TOF group, suggesting the possible impact of the pandemic. Results also indicated that matching altered characteristics such as age at operation that may limit the temporal effects and optimize secondary analyses. Using optimal contemporary cases and historical data based on this study will assist in developing a comprehensive study design for a future efficacy/effectiveness trial.

  • Open Access

    Development, Physicochemical Characteristics and Pharmacokinetics of a New Sustained-Release Bilayer Tablet Formulation of Tramadol with an Immediate-Release Component for Twice-Daily Administration

    by Naoki Ishitsubo, Shinji Oguro, Hirotoshi Shimahashi, Masato Kawanishi, Takeshi Adachi, Kenji Mitsuda, Nobuyuki Ishibashi

    Background and Objective There are some potential concerns about the currently marketed solid oral dosage forms of tramadol, including decreased adherence to immediate-release (IR) formulations due to the high number of doses taken each day and the slow rise in the blood tramadol concentration after administration of sustained-release (SR) formulations, which may not achieve a rapid analgesic effect. To overcome these potential concerns, a twice-daily double-layered tablet formulation of tramadol comprising IR and SR layers was developed. This article reports studies that assessed its physicochemical and pharmacokinetic properties. Methods Dissolution tests of five bilayer tablet formulations (designated tablets A–E) and pharmacokinetic studies of tablets A and B were conducted to investigate the appropriate ratio of the IR/SR layers in the double-layered tablet. Additionally, pharmacokinetic studies of three finished dosage formulations (tablets C–E) were performed in healthy adult males to investigate the effect of food intake on drug absorption. Results Adjusting the excipients and tramadol content in the IR and SR layers of tablets A–E altered their dissolution profiles in a manner that could be predicted based on their compositions. The IR layer was released within 15 min, and the SR layer was slowly released over 10 h. In the pharmacokinetic study, the time to maximum plasma concentration (tmax) of tramadol after administration of tablets A (IR:SR: 20:80 mg) and B (40:60 mg) was shorter than that of a commercially available SR tablet, and the half-life (t1/2) was longer than that of a commercially available IR tablet. For tablets C–E, administration after food did not affect the area under the concentration-time curve (AUC) or maximum drug concentration (Cmax) of tramadol, but the tmax was prolonged by about 1 h compared with administration in fasting conditions. The mean ± standard deviation tmax and t1/2 for tablet D (IR:SR: 35:65 mg) in the fasting condition was 1.09 ± 0.56 h and 7.82 ± 0.85 h, respectively. The respective values in the fed condition were 2.47 ± 1.06 h and 7.12 ± 0.85 h, respectively. Conclusions To address the potential concerns regarding existing formulations of tramadol, a twice-daily, extended-release bilayer formulation of tramadol consisting of an IR and SR layer was developed. Pharmacokinetic studies confirmed that the plasma tramadol concentration increased quickly after administration and was maintained over a long period of time.


  • Open Access

    Mesenchymal Stromal Cell Delivery Via Cardiopulmonary Bypass Provides Neuroprotection in a Juvenile Porcine Model

    by Kamil Sarkislali, Kei Kobayashi, Nemanja Sarić, Takuya Maeda, Soichiro Henmi, Fahad A. Somaa, Ankush Bansal, Shao Ching Tu, Camille Leonetti, Chao-Hsiung Hsu, et al.